Survival Prospects and Circumstances of Death in
Contemporary Adult Congenital Heart Disease Patients
Under Follow-Up at a Large Tertiary CentreCLINICAL
PERSPECTIVE
by Gerhard-Paul Diller, Aleksander Kempny, Rafael Alonso-Gonzalez, Lorna Swan,
Anselm Uebing, Wei Li, Sonya Babu-Narayan, Stephen J. Wort, Konstantinos
Dimopoulos, and Michael A. Gatzoulis
Circulation
Volume 132(22):2118-2125
December 1, 2015
Copyright © American Heart Association, Inc. All rights reserved.
Cumulative incidence of cardiac and noncardiac death with 95% confidence intervals (dotted
line) for (A) the entire study cohort and (B) stratified by disease complexity according to the
Bethesda classification based on the results of competing risk model.
Gerhard-Paul Diller et al. Circulation. 2015;132:2118-2125
Copyright © American Heart Association, Inc. All rights reserved.
A, Cumulative incidence of pneumonia and cancer death with 95% confidence intervals based
on the results of competing risk model.
Gerhard-Paul Diller et al. Circulation. 2015;132:2118-2125
Copyright © American Heart Association, Inc. All rights reserved.
Standardized mortality ratios (SMR) in various subgroups of patients.
Gerhard-Paul Diller et al. Circulation. 2015;132:2118-2125
Copyright © American Heart Association, Inc. All rights reserved.
Projected 5-year mortality rates for 40-year-old ACHD patients compared with that expected for
the general UK population based on the results of the standardized mortality ratio (SMR)
analysis.
Gerhard-Paul Diller et al. Circulation. 2015;132:2118-2125
Copyright © American Heart Association, Inc. All rights reserved.
Mortality in subgroups of patients compared with mortality in age-matched UK population.
Gerhard-Paul Diller et al. Circulation. 2015;132:2118-2125
Copyright © American Heart Association, Inc. All rights reserved.